Lexeo Therapeutics (LXEO) Enterprise Value (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Enterprise Value of -$193.0 million for Q1 2026, down 6.2% sequentially from -$181.8 million in Q4 2025, and down 93.37% YoY from -$2.9 billion in Q1 2025.
Lexeo Therapeutics (LXEO) Enterprise Value (2022 - 2026) Analysis & Trends
Lexeo Therapeutics has reported Enterprise Value for 5 years, with the latest figure at -$193.0 million in Q1 2026.
- Quarterly Enterprise Value fell 93.37% year-over-year to -$193.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$193.0 million (down 93.37% YoY) and the FY2025 annual result came in at -$181.8 million, down 49.58% from the prior year.
- Enterprise Value declined to -$193.0 million in Q1 2026 per LXEO's latest filing, from -$181.8 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$35.4 million in Q3 2023 and troughed at -$195.1 million in Q1 2024.
- A 5-year average of -$131.3 million and a median of -$122.8 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 62.35% in 2023, then tumbled 342.89% in 2024.
- Over 5 years, Enterprise Value stood at -$77.3 million in 2022, then plunged by 57.06% to -$121.5 million in 2023, then slipped by 0.04% to -$121.5 million in 2024, then sank by 49.58% to -$181.8 million in 2025, then decreased by 6.2% to -$193.0 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$193.0 million, -$181.8 million, and -$122.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Lexeo Therapeutics | 397.10 Mn | 397.10 Mn | - | -211.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -211.70 Mn |
| Mar 31, 2026 | -193.04 Mn |
| Dec 31, 2025 | -181.77 Mn |
| Sep 30, 2025 | -122.76 Mn |
| Jun 30, 2025 | -132.89 Mn |
| Mar 31, 2025 | -99.83 Mn |
| Dec 31, 2024 | -121.52 Mn |
| Sep 30, 2024 | -157.00 Mn |
| Jun 30, 2024 | -174.98 Mn |
| Mar 31, 2024 | -195.06 Mn |
| Dec 31, 2023 | -121.47 Mn |
| Sep 30, 2023 | -35.45 Mn |
| Dec 31, 2022 | -77.34 Mn |
| Sep 30, 2022 | -94.15 Mn |